Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
45b0Lq0J0HymgGeC
Listen
